Prostate volume may have influenced finasteride associated high-grade disease incidence

Adams, Stacey L.; Haigh, Christen; Harris, Jason
August 2009
Hem/Onc Today;8/10/2009, Vol. 10 Issue 15, p25
The article discusses a research which revealed the possible influence of prostate volume on the incidence of high-grade disease associated with finasteride.


Related Articles

  • Proscar can cause ill effects.  // HealthFacts;Nov96, Vol. 21 Issue 210, p3 

    Reports on the effects of the drug finasteride with the brand Proscar. Use for treating symptoms of an enlarged prostate; Occurrence of gynecomastia in men.

  • Use of Transgenic Mice as Models for Prostate Cancer Chemoprevention. Nguewa, P. A.; Calvo, A. // Current Molecular Medicine;Nov2010, Vol. 10 Issue 8, p705 

    Prostate cancer is a long latency type of tumor that usually develops in men older than 50 years of age. Prostate epithelial neoplasia (PIN), the initial malignant lesion, progresses to invasive carcinoma over the course of years. Because of the particular features of prostate carcinogenesis,...

  • 2012 season peaks late. Johnsen, Michael // Drug Store News;2/27/2012, Vol. 34 Issue 3, p44 

    The article reports that the expected illness peak for cough, cold, and flu season in the U.S. is in the late February or early March 2012.

  • Long-Term Sexual and Psychological Adverse Effects of Finasteride. Kuritzky, Louis // Infectious Disease Alert;Dec2012 Clinical Briefs in Primary Care, p23 

    The article offers information on a study that deals with persistent diminution in penile relaxation and contraction subsequent to finasteride.

  • Medicines can shrink the prostate gland. Donohue, Paul G. // Adirondack Daily Enterprise;3/24/2010, Vol. 117 Issue 71, p6 

    The article provides answers related to health questions such as the effectiveness of a medicine called Proscar to shrink the prostate gland and a substitute drug for quinine tablets for leg cramps which has been removed from drugstore shelves by the U.S. Food and Drug Administration.

  • Finasteride/hypericum interaction.  // Reactions Weekly;1/29/2011, Issue 1336, p22 

    he article describes the case report of a male patient who developed benign prostate hyperplasia and an elevated prostate-specific antigen (PSA) levels following treatment with finasteride combined with hypericum.

  • Finasteride.  // Reactions Weekly;4/3/2010, Issue 1295/1296, p20 

    The article describes the case of a 69-year-old man who experienced a urticarial rush after taking finasteride for benign prostatic hypertrophy.

  • Finasteride: an effective treatment for male pattern hair loss.  // Modern Medicine;Jan99, Vol. 67 Issue 1, p47 

    Discusses the abstract `Finasteride in the Treatment of Men With Androgenetic Alopecia' by K.D. Kaufman, E.A. Olsen, et al., published in the October 1998 issue of the `Journal of the American Academy of Dermatology' periodical.

  • Combination therapy lowers BPH progression risk by 67%. Snider, Tim // Urology Times;Aug2002, Vol. 30 Issue 8, p1 

    Focuses on the benefits of the combination therapy using finasteride and doxazosin. Reduction of the risk for benign prostatic hyperplasia; Delay of the disease progression; Decrease in the incidence of the disease.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics